Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

There may be a "promising new strategy" in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia ...

The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...

What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...

A drug that has long been used to treat two common men’s health conditions could have some unexpected benefits. Finasteride — more commonly known as Propecia or Proscar — has treated male pattern ...

A new immunotherapy drug used in a prostate cancer clinical trial is showing early promise in possible treatment of the disease.

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

(MENAFN- EIN Presswire) EINPresswire/ -- The Prostate Cancer Drugs Market was valued at US$ 13.22 billion in 2024 and is projected to reach US$ 28.10 billion by 2033, growing at a CAGR of 8.1 percent ...

At University of Utah Health, our urologists specialize in helping men achieve better health with top-notch specialty care and the latest advances in treatment and therapies. We provide care for a ...